Proair hfa and Denavir drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among people who take Proair hfa and Denavir. Common interactions include fatigue among females and fractured coccyx among males.

The phase IV clinical study analyzes what interactions people who take Proair hfa and Denavir have. It is created by eHealthMe based on reports of 36 people who take Proair hfa and Denavir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

36 people who take Proair hfa and Denavir together, and have interactions are studied.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 48,155 Proair hfa users for its effectiveness, alternative drugs and more.

What is Denavir?

Denavir has active ingredients of penciclovir sodium. eHealthMe is studying from 542 Denavir users for its effectiveness, alternative drugs and more.

Number of Proair hfa and Denavir reports submitted per year:

Proair hfa and Denavir drug interactions.

Common Proair Hfa and Denavir drug interactions by gender *:


  1. Fatigue
  2. Respiratory tract infection
  3. Tubulointerstitial nephritis
  4. Anaemia
  5. Haematochezia
  6. Headache
  7. Muscle spasms
  8. Skin discolouration
  9. Abdominal pain
  10. Alopecia


  1. Fractured coccyx
  2. Gout
  3. Sjogren's syndrome

Common Proair Hfa and Denavir drug interactions by age *:












  1. Breath odour
  2. Dysgeusia
  3. Gastrooesophageal reflux disease
  4. Rash
  5. Ulcer


  1. Decreased appetite
  2. Fungal skin infection
  3. Musculoskeletal discomfort
  4. Pain
  5. Pneumonia
  6. Chronic kidney disease
  7. Renal failure
  8. Tubulointerstitial nephritis
  9. Atrial fibrillation
  10. Cardiovascular disorder


  1. Chest pain
  2. Chronic kidney disease
  3. Diarrhoea
  4. Dizziness
  5. Growth of eyelashes
  6. Headache
  7. Heart rate irregular
  8. Hypothyroidism
  9. Lip swelling
  10. Micturition disorder

Common conditions people have *:

  1. High Blood Pressure: 12 people, 33.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 33.33%
  3. Nausea (feeling of having an urge to vomit): 12 people, 33.33%
  4. Stable Angina (a constant chest pain): 11 people, 30.56%
  5. Immunodeficiency Common Variable: 11 people, 30.56%
  6. High Blood Cholesterol: 11 people, 30.56%
  7. Depression: 11 people, 30.56%
  8. Pain: 11 people, 30.56%
  9. Neuralgia (pain in one or more nerves): 11 people, 30.56%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and Denavir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Proair hfa and Denavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Proair hfa interactions:

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and penciclovir sodium (the active ingredients of Proair hfa and Denavir, respectively), and Proair hfa and Denavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Proair hfa and Denavir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: